https://www.selleckchem.com/products/apcin.html
tonia (EU48695) and Karolinska Institute. Authors do not have any conflict of interest. We aimed to develop a gene expression-based prognostic signature for isocitrate dehydrogenase (IDH) wild-type glioblastoma using clinical trial datasets representative of glioblastoma clinical trial populations. Samples were collected from newly diagnosed patients with IDH wild-type glioblastoma in the ARTE, TAMIGA, EORTC 26101 (referred to as "ATE", AVAglio, and GLARIUS trials, or treated at UCLA. Transcriptional profiling was achieved with the NanoS
Mi piace
Commento
Condividi
